市場調査レポート

商品コード

1612126

脱毛症治療市場：疾患タイプ、投与経路、性別、治療オプション、エンドユーザー別-2025-2030年の世界予測

Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Global Forecast 2025-2030

出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 187 Pages
納期: 即日から翌営業日

カスタマイズ可能

適宜更新あり

価格

PDF, Excel & 1 Year Online Access (Single User License)

USD 3,939 578,323円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。オンラインプラットフォーム上で1年間、何度でもレポートをダウンロードする事が可能な上、定期的に更新される情報にアクセスする事が可能です（更新は年3-4回程度）。

PDF, Excel & 1 Year Online Access (2-5 User License)

USD 4,249 623,838円

レポートPDF及びExcelを5名までご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。オンラインプラットフォーム上で1年間、何度でもレポートをダウンロードする事が可能な上、定期的に更新される情報にアクセスする事が可能です（更新は年3-4回程度）。

PDF, Excel & 1 Year Online Access (Site License)

USD 5,759 845,536円

レポートPDF及びExcelを、同じ地理上の位置に所在する事業所内に所属の全ての方にご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。オンラインプラットフォーム上で1年間、何度でもレポートをダウンロードする事が可能な上、定期的に更新される情報にアクセスする事が可能です（更新は年3-4回程度）。

PDF, Excel & 1 Year Online Access (Enterprise User License)

USD 6,969 1,023,188円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。オンラインプラットフォーム上で1年間、何度でもレポートをダウンロードする事が可能な上、定期的に更新される情報にアクセスする事が可能です（更新は年3-4回程度）。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

脱毛症治療市場の2023年の市場規模は48億5,000万米ドルで、2024年には52億7,000万米ドルに達すると予測され、CAGR 8.89％で成長し、2030年には88億1,000万米ドルに達すると予測されています。

脱毛症治療市場の範囲と定義には、円形脱毛症、男性型脱毛症、その他の頭皮疾患などの症状に伴う脱毛の対策を目的とした治療的介入と製品が含まれます。このような治療の必要性は、脱毛が人の生活の質や自尊心に大きな影響を与えるという心理的影響によって強調されています。治療には、局所治療、内服薬、植毛などの外科的処置、血小板を豊富に含むプラズマやレーザー治療などの新しい治療法が含まれます。最終用途分野には、主に皮膚科クリニック、エステティックセンター、個人のホームユーザーが含まれます。主な成長要因としては、脱毛症治療に対する意識の高まり、治療技術の進歩、ヘルスケア支出の増加などが挙げられます。特筆すべきは、生物製剤の登場と遺伝子治療の研究開発の活発化が、市場プレーヤーに新たな機会をもたらしていることです。潜在的なビジネスチャンスは、個別化医療のアプローチと、手頃な価格のソリューションによる新興市場でのアクセス拡大にあります。

主な市場の統計
基準年［2023］	48億5,000万米ドル
予測年[2024］	52億7,000万米ドル
予測年［2030］	88億1,000万米ドル
CAGR（%）	8.89%

しかし、同市場は、高額な治療費、患者の反応のばらつき、潜在的な副作用、規制上のハードルなど、いくつかの限界や課題に直面しています。さらに、美容治療に関連する文化的認識や偏見が、特定の地域での成長を阻害する可能性もあります。これらの課題を克服し、成長を促進するために、技術革新と研究は、ペプチドベースの治療やナノセラピーのような新しい送達メカニズムなど、副作用の少ない、より安全で効果的な治療法の開発に焦点を当てることができると思われます。毛髪障害の遺伝的基盤を理解する最先端の研究は、治療の選択肢をさらに調整する可能性があります。市場力学は、競争圧力と急速な技術進歩を特徴とするダイナミックな市場であり、継続的なイノベーションの必要性を示唆しています。企業は、研究機関や医療提供者との共同研究や戦略的パートナーシップの育成に投資することで、研究開発能力を強化し、製品ポートフォリオを拡大することで、競争優位性を獲得できる可能性があります。

市場力学：急速に進化する脱毛症治療市場の主要市場インサイトを公開

脱毛症治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

市場促進要因
- 男性型脱毛症および円形脱毛症の罹患率の増加
- 脱毛と植毛に対する意識の高まり
- 所得水準の上昇とヘルスケア支出の増加
市場抑制要因
- 脱毛症治療に対する償還政策の欠如
市場機会
- 新しい円形脱毛症治療と治療薬の出現
- 自毛植毛クリニックへの投資の増加と拡大
市場の課題
- 一部の脱毛症治療法の有効性と副作用に関する問題

ポーターのファイブフォース：脱毛症治療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：脱毛症治療市場における外部からの影響の把握

外部マクロ環境要因は、脱毛症治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：脱毛症治療市場における競合情勢の把握

脱毛症治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス：脱毛症治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、脱毛症治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：脱毛症治療市場における成功への道筋を描く

脱毛症治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

市場力学
- 促進要因
  - 男性型脱毛症および円形脱毛症の発生率の増加
  - 脱毛症と移植に関する意識の高まり
  - 所得水準の上昇とヘルスケア費の増加
- 抑制要因
  - 脱毛症治療に対する償還ポリシーの欠如
- 機会
  - 円形脱毛症の新しい治療法と治療薬の出現
  - 毛髪移植クリニックへの投資の増加と拡大
- 課題
  - 一部の脱毛治療療法に関連する有効性と副作用に関する問題
市場セグメンテーション分析
- 疾患タイプ：全身性脱毛症および全頭脱毛症に対する効果的な治療法の必要性が高まっている
- エンドユーザー：利便性と費用対効果による在宅ケア治療
ポーターのファイブフォース分析
PESTEL分析
- 政治的
- 経済
- 社交
- 技術的
- 法律上
- 環境

第6章脱毛症治療市場：疾患タイプ別

円形脱毛症
全頭脱毛症
全身性脱毛症
男性型脱毛症
瘢痕性脱毛症
牽引性脱毛症

第7章脱毛症治療市場：投与経路別

注射可能
オーラル
話題

第8章脱毛症治療市場性別

女性
男

第9章脱毛症治療市場治療オプション別

美容治療
- ヘアファイバーパウダー
- 頭皮マイクロピグメンテーション
治療
- アントラリン
- コルチコステロイド
- JAK阻害剤
- メトトレキサート
- 局所免疫療法
外科的治療
- 毛包単位抽出
- 毛髪移植手術
- 頭皮縮小治療

第10章脱毛症治療市場：エンドユーザー別

皮膚科クリニック
在宅ケア環境

第11章南北アメリカの脱毛症治療市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第12章アジア太平洋地域の脱毛症治療市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第13章欧州・中東・アフリカの脱毛症治療市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第14章競合情勢

市場シェア分析2023
FPNVポジショニングマトリックス, 2023
競合シナリオ分析
- リリーのオルミエント（バリシチニブ）がカナダで重度の円形脱毛症の治療として承認
- HopeMed、革新的な男性型遺伝子治療薬の第2相臨床試験を進める脱毛症治療
- FDAがファイザーのLITFULO（リトレシチニブ）を重症患者に承認脱毛症治療
戦略分析と提言

企業一覧

AbbVie Inc.
Aclaris Therapeutics, Inc.
AnaptysBio Inc.
Apira Science, Inc.
Apple Therapeutics Private Limited
Arcutis Biotherapeutics, Inc.
Biocon Limited
Cipla, Inc.
Daiichi Sankyo Inc.
DR. KURT WOLFF GMBH & CO. KG
Dr. Reddy's Laboratories Ltd
Eli Lilly and Company
Fagron NV
Follica, Inc.
HCell Inc.
iRestore Hair Growth System
KNOW Bio LLC
Merck & Co.
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
RepliCel Life Sciences Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd
Transitions Hair Pty Ltd.
Viviscal

図表

LIST OF FIGURES

FIGURE 1. ALOPECIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. ALOPECIA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ALOPECIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. ALOPECIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. ALOPECIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ALOPECIA TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CICATRICIAL ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TRACTION ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR FIBER POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP MICROPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANTHRALIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FOLLICULAR UNIT EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR TRANSPLANT SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP REDUCTION TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HOMECARE SETTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. CANADA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 69. CANADA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 70. CANADA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. CANADA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. CANADA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. CANADA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. CHINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 109. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. CHINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 111. CHINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 112. CHINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. CHINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 114. CHINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 115. CHINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. INDIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 117. INDIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. INDIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 119. INDIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 120. INDIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 121. INDIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. INDIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 123. INDIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 133. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 135. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 136. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 139. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 147. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 155. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 163. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 171. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 181. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 183. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 184. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 185. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 186. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 187. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 195. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 205. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 208. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 209. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 210. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 211. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 212. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 216. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 217. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 218. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 219. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 220. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 222. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 224. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 225. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 226. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 227. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 228. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 230. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 232. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 233. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 234. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 235. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 236. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 238. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 240. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 241. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 242. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 243. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 244. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 252. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. ITALY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 254. ITALY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 255. ITALY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 256. ITALY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 257. ITALY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 258. ITALY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 259. ITALY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 260. ITALY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 280. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 281. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 282. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 283. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 284. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. POLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 286. POLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. POLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 288. POLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 289. POLAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 290. POLAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 291. POLAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 292. POLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. QATAR ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 294. QATAR ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 295. QATAR ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 296. QATAR ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 297. QATAR ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 298. QATAR ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 299. QATAR ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 300. QATAR ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 326. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 327. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 328. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 329. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 330. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 331. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 332. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 338. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 339. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 340. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)

TABLE

Product Code: MRR-A339DAEFA47E

The Alopecia Treatment Market was valued at USD 4.85 billion in 2023, expected to reach USD 5.27 billion in 2024, and is projected to grow at a CAGR of 8.89%, to USD 8.81 billion by 2030.

The scope and definition of the alopecia treatment market encompass therapeutic interventions and products aimed at counteracting hair loss associated with conditions like alopecia areata, androgenetic alopecia, and other scalp disorders. The necessity for such treatments is underscored by the psychological impact of hair loss, which can significantly affect a person's quality of life and self-esteem. Applications include topical treatments, oral medications, surgical procedures like hair transplantation, and emerging therapies such as platelet-rich plasma and laser treatments. End-use segments primarily involve dermatology clinics, aesthetic centers, and individual home users. Key growth factors include rising awareness about alopecia treatments, advancements in treatment technologies, and increased healthcare expenditure. Notably, the advent of biologics and increased R&D in gene therapy present fresh opportunities for market players. Potential opportunities lie in personalized medicine approaches and expanding access in emerging markets through affordable solutions.

KEY MARKET STATISTICS
Base Year [2023]	USD 4.85 billion
Estimated Year [2024]	USD 5.27 billion
Forecast Year [2030]	USD 8.81 billion
CAGR (%)	8.89%

However, the market faces several limitations and challenges, including high treatment costs, variability in patient response, potential side effects, and regulatory hurdles. Additionally, cultural perceptions and stigmas associated with aesthetic treatments might impede growth in certain regions. To navigate these challenges and foster growth, innovation and research could focus on developing safer, more effective treatments with fewer side effects, such as peptide-based interventions and novel delivery mechanisms like nanotherapy. Cutting-edge research in understanding the genetic basis of hair disorders could further tailor treatment options. The alopecia treatment market is dynamic, characterized by competitive pressures and rapid technological advancements, suggesting a need for continuous innovation. Companies may gain a competitive edge by investing in collaborations and fostering strategic partnerships with research institutions and health care providers, thereby enhancing their R&D capabilities and expanding their product portfolios.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Alopecia Treatment Market

The Alopecia Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Increasing incidence of androgenetic alopecia and alopecia areata diseases
- Growing awareness about hair loss and transplantation
- Rise in income levels and increased healthcare spending
Market Restraints
- Lack of reimbursement policies for alopecia treatments
Market Opportunities
- Emergence of new alopecia areata treatments and therapeutics
- Rising investments and expansion of hair transplant clinics
Market Challenges
- Issues associated with efficacy and side-effects related to some hair loss treatment therapies

Porter's Five Forces: A Strategic Tool for Navigating the Alopecia Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Alopecia Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Alopecia Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Alopecia Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Alopecia Treatment Market

A detailed market share analysis in the Alopecia Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Alopecia Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Alopecia Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Alopecia Treatment Market

A strategic analysis of the Alopecia Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aclaris Therapeutics, Inc., AnaptysBio Inc., Apira Science, Inc., Apple Therapeutics Private Limited, Arcutis Biotherapeutics, Inc., Biocon Limited, Cipla, Inc., Daiichi Sankyo Inc., DR. KURT WOLFF GMBH & CO. KG, Dr. Reddy's Laboratories Ltd, Eli Lilly and Company, Fagron NV, Follica, Inc., HCell Inc., iRestore Hair Growth System, KNOW Bio LLC, Merck & Co., Pfizer Inc., Regeneron Pharmaceuticals, Inc., RepliCel Life Sciences Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Transitions Hair Pty Ltd., and Viviscal.

Market Segmentation & Coverage

This research report categorizes the Alopecia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Disease Type, market is studied across Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, Cicatricial Alopecia, and Traction Alopecia.
Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
Based on Gender, market is studied across Female and Male.
Based on Treatment Option, market is studied across Cosmetic Treatment, Medical Treatment, and Surgical Treatment. The Cosmetic Treatment is further studied across Hair Fiber Powders and Scalp Micropigmentation. The Medical Treatment is further studied across Anthralin, Corticosteroid, JAK Inhibitors, Methotrexate, and Topical Immunotherapy. The Surgical Treatment is further studied across Follicular Unit Extraction, Hair Transplant Surgery, and Scalp Reduction Treatment.
Based on End User, market is studied across Dermatology Clinics and Homecare Setting.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing incidence of androgenetic alopecia and alopecia areata diseases
  - 5.1.1.2. Growing awareness about hair loss and transplantation
  - 5.1.1.3. Rise in income levels and increased healthcare spending
- 5.1.2. Restraints
  - 5.1.2.1. Lack of reimbursement policies for alopecia treatments
- 5.1.3. Opportunities
  - 5.1.3.1. Emergence of new alopecia areata treatments and therapeutics
  - 5.1.3.2. Rising investments and expansion of hair transplant clinics
- 5.1.4. Challenges
  - 5.1.4.1. Issues associated with efficacy and side-effects related to some hair loss treatment therapies
5.2. Market Segmentation Analysis
- 5.2.1. Disease Type: Growing need for effective treatments for alopecia universalis and alopecia totalis
- 5.2.2. End User: homecare treatments owing to their Convenience and cost-effectiveness
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Alopecia Treatment Market, by Disease Type

6.1. Introduction
6.2. Alopecia Areata
6.3. Alopecia Totalis
6.4. Alopecia Universalis
6.5. Androgenetic Alopecia
6.6. Cicatricial Alopecia
6.7. Traction Alopecia

7. Alopecia Treatment Market, by Route of Administration

7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Topical

8. Alopecia Treatment Market, by Gender

8.1. Introduction
8.2. Female
8.3. Male

9. Alopecia Treatment Market, by Treatment Option

9.1. Introduction
9.2. Cosmetic Treatment
- 9.2.1. Hair Fiber Powders
- 9.2.2. Scalp Micropigmentation
9.3. Medical Treatment
- 9.3.1. Anthralin
- 9.3.2. Corticosteroid
- 9.3.3. JAK Inhibitors
- 9.3.4. Methotrexate
- 9.3.5. Topical Immunotherapy
9.4. Surgical Treatment
- 9.4.1. Follicular Unit Extraction
- 9.4.2. Hair Transplant Surgery
- 9.4.3. Scalp Reduction Treatment

10. Alopecia Treatment Market, by End User

10.1. Introduction
10.2. Dermatology Clinics
10.3. Homecare Setting

11. Americas Alopecia Treatment Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Alopecia Treatment Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Alopecia Treatment Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
- 14.3.1. Lilly's Olumiant (Baricitinib) Authorized in Canada for Severe Alopecia Areata Treatment
- 14.3.2. HopeMed Advances Phase II Clinical Trials for Innovative Androgenetic Alopecia Treatment
- 14.3.3. FDA Approves Pfizer's LITFULO (Ritlecitinib) for Severe Alopecia Treatment
14.4. Strategy Analysis & Recommendation

Companies Mentioned

1. AbbVie Inc.
2. Aclaris Therapeutics, Inc.
3. AnaptysBio Inc.
4. Apira Science, Inc.
5. Apple Therapeutics Private Limited
6. Arcutis Biotherapeutics, Inc.
7. Biocon Limited
8. Cipla, Inc.
9. Daiichi Sankyo Inc.
10. DR. KURT WOLFF GMBH & CO. KG
11. Dr. Reddy's Laboratories Ltd
12. Eli Lilly and Company
13. Fagron NV
14. Follica, Inc.
15. HCell Inc.
16. iRestore Hair Growth System
17. KNOW Bio LLC
18. Merck & Co.
19. Pfizer Inc.
20. Regeneron Pharmaceuticals, Inc.
21. RepliCel Life Sciences Inc.
22. Sun Pharmaceutical Industries Ltd.
23. Teva Pharmaceutical Industries Ltd
24. Transitions Hair Pty Ltd.
25. Viviscal

脱毛症治療市場：疾患タイプ、投与経路、性別、治療オプション、エンドユーザー別-2025-2030年の世界予測

Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Global Forecast 2025-2030

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 脱毛症治療市場：疾患タイプ別

第7章 脱毛症治療市場：投与経路別

第8章 脱毛症治療市場性別

第9章 脱毛症治療市場治療オプション別

第10章 脱毛症治療市場：エンドユーザー別

第11章 南北アメリカの脱毛症治療市場

第12章 アジア太平洋地域の脱毛症治療市場

第13章 欧州・中東・アフリカの脱毛症治療市場

第14章 競合情勢